+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase Not Applicable
Age: 18Years +
All Genders
ID04097145

Study to Evaluate Edwards PASCAL System and Medical Therapy for Severe Tricuspid Regurgitation Compared to Medical Therapy Alone

Led by Edwards Lifesciences · Updated on 2026-09-14

1270

Participants Needed

79

Research Sites

208 weeks

Total Duration

AI-Summary

What This Trial Is About

Researchers are evaluating the safety and effectiveness of the Edwards PASCAL Transcatheter Valve Repair System for patients with severe tricuspid regurgitation who have symptoms and are at an intermediate or higher risk of mortality from tricuspid valve surgery. This randomized, controlled trial compares the device combined with optimal medical therapy OMT to OMT alone. The study is conducted at multiple centers and sponsored by Edwards Lifesciences. Participants are assigned to one of several groups receiving the Edwards PASCAL system plus OMT, OMT alone, or the device with OMT if not eligible for randomization. The transcatheter procedure repairs the tricuspid valve without open surgery. Follow-up visits occur at hospital discharge, 30 days, 3 months, 6 months, and then annually for up to 5 years, allowing long-term monitoring of outcomes. During the study, participants will undergo assessments including quality of life questionnaires, heart imaging, and monitoring for heart failure hospitalizations, mortality, and valve-related events. The main outcome measured at 6 months includes a combination of death, heart device implantation or transplant, valve interventions, hospital admissions for heart failure, and improvement in quality of life. Safety and effectiveness data will be collected throughout the follow-up period of up to 5 years.

CONDITIONS

Brief Title

Edwards PASCAL Transcatheter Valve Repair System Pivotal Clinical Trial

Research Team

E

Edwards TMTT Clinical Affairs

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here